- Home
- APD vs COR Comparison
APD vs COR Comparison
Compare APD & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APD | COR |
|---|---|---|
| Founded | 1940 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.6B | 68.5B |
| IPO Year | 1994 | 2001 |
Fundamental Metrics
Financial Performance| Metric | APD | COR |
|---|---|---|
| Price | $281.13 | $281.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | $308.83 | ★ $390.62 |
| AVG Volume (30 Days) | 1.0M | ★ 1.5M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.39% | 0.77% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | 6.23 | ★ 11.27 |
| Revenue | $12,037,300,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $6.02 | $8.89 |
| Revenue Next Year | $6.21 | $6.75 |
| P/E Ratio | $44.61 | ★ $25.01 |
| Revenue Growth | N/A | ★ 9.31 |
| 52 Week Low | $229.11 | $244.82 |
| 52 Week High | $307.96 | $377.54 |
Technical Indicators
Market Signals| Indicator | APD | COR |
|---|---|---|
| Relative Strength Index (RSI) | 42.60 | 54.84 |
| Support Level | $277.37 | $261.29 |
| Resistance Level | $286.22 | $326.95 |
| Average True Range (ATR) | 5.82 | 5.17 |
| MACD | -0.24 | 3.51 |
| Stochastic Oscillator | 37.58 | 85.15 |
Price Performance
Historical ComparisonAbout APD Air Products and Chemicals Inc.
Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the world's largest supplier of hydrogen and helium. It has a unique portfolio serving customers across industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated roughly $12 billion in revenue in fiscal 2025.
About COR Cencora Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.